Company intelligence / Profile preview

Nuan Bio

Cambridge, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Nuan Bio is an early-stage biotechnology company focused on developing breakthrough cell therapies, specifically engineered CAR-T cells, to treat solid tumors. The company was founded by Dr. Frank Fan, the former Chief Scientific Officer of Legend Biotech, who played a key role in the development of the BCMA-targeting CAR-T therapy Carvykti.

Therapeutic areas: Oncology
Modalities: CAR-T cell therapyCell therapyT cell therapy
Industry: Biotech

Beyond the preview

Go deeper on Nuan Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuan Bio.

Explore the full profile